1303-1314
Review
A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment
Loredana G. Marcu and E. Yeoh
1315-1321
Original Paper
A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland
Hong He, Guanfu Chen, Liang Zhou and Yanmin Liu
1323-1330
Original Paper
Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer
Wei-Qing Xu, Ling-Jun Song, Qiang Liu, Lei Zhao and Lin Zheng, et al.
1331-1339
Original Paper
Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance
Guan Zhen Yu, Ying Chen and Jie Jun Wang
1341-1349
Original Paper
Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma
Xiaoya Yang, Gang Xiong, Xuedan Chen, Xueqing Xu and Kai Wang, et al.
1351-1358
Original Paper
B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder?
Petra Richter, Markus Tost, Marcus Franz, Annelore Altendorf-Hofmann and Kerstin Junker, et al.
1359-1367
Original Paper
High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection
Jie Hu, Yang Xu, Zao-Zhuo Shen, Zheng Wang and Qing Lu, et al.
1369-1376
Original Paper
ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma
Yao Jin, Zhang Quan Bin, Huang Qiang, Chu Liang and Chen Hua, et al.
1377-1386
Original Paper
Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo
Michael Pohl, I. Stricker, A. Schoeneck, K. Schulmann and S. Klein-Scory, et al.
1387-1391
Original Paper
Open AccessInterdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma
Günter Emons and Rainer Kimmig
1393-1401
Original Paper
RETRACTED ARTICLE: Overexpression of Cks1 is associated with poor survival by inhibiting apoptosis in breast cancer
Xiao-Chun Wang, Li-Li Tian, Jing Tian, Hai-Liang Wu and Ai-min Meng
1403-1412
Original Paper
Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China
Jia Fan, Guang-Shun Yang, Zhi-Ren Fu, Zhi-Hai Peng and Qiang Xia, et al.
1413-1420
Original Paper
Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications
Hsi-Huang Tseng, Jan-Gowth Chang, Yaw-Huei Hwang, Kun-Tu Yeh and Yao-Li Chen, et al.
1421-1428
Original Paper
Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
Takeshi Hara, Hisashi Tsurumi, Naoe Goto, Nobuhiro Kanemura and Takeshi Yoshikawa, et al.
1429-1435
Original Paper
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
Stefan Wilop, Sabine von Hobe, Martina Crysandt, Albert Esser and Rainhardt Osieka, et al.
1437-1445
Original Paper
A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma
Chong Zhong, Rong-ping Guo, Jin-qing Li, Ming Shi and Wei Wei, et al.
1447-1453
Original Paper
The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma
Ning Zhang, Lu Wang, Ying Liang, Yi-Ming Zhao and Qiong Xue, et al.
1455-1462
Original Paper
Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse model
Edwin Herrmann, Arne Tiemann, Elke Eltze, Christian Bolenz and Christoph Bremer, et al.
1463-1470
Original Paper
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations
Per Arne Andresen, Ketil Heimdal, Kristin Aaberg, Kristin Eklo and Sarah Ariansen, et al.
1471
Erratum
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations
Per Arne Andresen, Ketil Heimdal, Kristin Aaberg, Katrine Eklo and Sarah Ariansen, et al.